Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01624363 · ClinicalTrials.gov registry record
Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 341
- Enrollment target
NCT01624363: Completed study, sponsored by Indiana University.
NCT01624363 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 341 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01624363 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 341 participants
- Enrollment target
Study Summary
The investigators are interested in performing a detailed examination of the pancreas via EUS (Endoscopic Ultra Sound)for patients referred for a non-pancreatic condition. The hypothesis is to make a statistical determination of how many pancreatic cysts the investigators discover incidentally.
Primary Outcome
The purpose of this study is to identify the prevalence of pancreatic cysts in patients undergoing EUS for non-pancreatic indications .
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-06 |
What the finished NCT01624363 record still lists
NCT01624363 is an observational study that tracks outcomes without assigning an intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01624363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01624363 about?
NCT01624363 is a clinical study titled "Prevalence of Pancreatic Cysts During Routine Endoscopic Ultra Sound". The investigators are interested in performing a detailed examination of the pancreas via EUS (Endoscopic Ultra Sound)for patients referred for a non-pancreatic condition. The hypothesis is to make a statistical determination of how many pancreatic cysts the investigators discover incidentally.
What is the current status of trial NCT01624363?
This trial is currently completed. The enrollment target is 341 participants. The study started on 2009-09. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01624363?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia